Fertility issues in women with gynecologic cancers

References

• Whitworth A. New options expand possibilities for fertility preservation in cancer patients. J. Natl Cancer Inst.98, 1358–1360 (2006).
   PubMedGoogle Scholar
• Maltaris T, Seufert R, Fischl F et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur. J. Obstet. Gynecol. Reprod. Biol.130, 148–155 (2007).
   PubMed Web of Science ®Google Scholar
• Del Priore G, Huang GS. Strategies for gynecologic cancers. In: Preservation of Fertility. Tuland T, Gosden R (Eds). Taylor and Francis Publishers, London UK and NY, USA, 7, 89–100 (2004).
   Google Scholar
• Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H. Reproduction beyond cancer: a message of hope for young women. Gynecol. Oncol.103, 1109–1121 (2006).
   PubMed Web of Science ®Google Scholar
• Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum. Reprod. Update7, 535–543 (2001).
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist11, 422–434 (2006).
   PubMed Web of Science ®Google Scholar
• Chao CKS, Brady LW, Perez CA, Brady LW. Hodgkin’s disease. In: Radiation Oncology: Management Decisions. (Second Edition). Lippincott, Williams and Wilkins, 52, 575–588 (2001).
   Google Scholar
• Byrne J, Fears TR, Gail MH et al. Early menopause in long-term survivors of cancer during adolescence. Am. J. Obstet. Gynecol.166, 788–793 (1992).
   PubMed Web of Science ®Google Scholar
• Meirow D, Epstein M, Lewis H et al. Administration of cyclophosphamide at different stages of follicular development in mice: effects on reproductive performance and fetal malformations. Hum. Reprod.16, 62–637 (2001).
   Google Scholar
• Kroman N, Jensen MB, Melbye M, Wohlfahrt J, Mouridsen HT. Should women be advised against pregnancy after breast-cancer treatment? Lancet350, 319–322 (1997).
   PubMed Web of Science ®Google Scholar
• Velentgas P, Daling JR, Malone KE et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer85, 2424–2432 (1999).
   PubMed Web of Science ®Google Scholar
• Del Priore G, Hatami M. Hormone replacement therapy in breast cancer patients and survivors. Curr. Womens Health Rep.3, 165–169 (2003).
   PubMedGoogle Scholar
• Shannon C, Smith IE. Breast cancer in adolescents and young women. Eur. J. Cancer39, 2632–2642 (2003).
   PubMed Web of Science ®Google Scholar
• Friedlander M, Thewes B. Counting the costs of treatment: the reproductive and gynecological consequences of adjuvant therapy in young women with breast cancer. Intern. Med. J.33, 372–379 (2003).
   PubMed Web of Science ®Google Scholar
• Cuzick J, Ambroisine L, Davidson N et al. LHRH-agonists in early breast cancer overview group. Use of luteinising-hormone-releasing-hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomized adjuvant trials. Lancet369, 1711–1722 (2007).
   PubMed Web of Science ®Google Scholar
• Emens LA, Davidson NE. Adjuvant hormonal therapy for premenopausal women with breast cancer. Clin. Cancer Res.9, S486–S494 (2003).
   Google Scholar
• The adjuvant breast cancer trials group. Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. J. Natl Cancer Inst.99, 516–525 (2007).
   PubMedGoogle Scholar
• Bedner R, Rzepka-Gorska I. Hysteroscopy with directed biopsy versus dilatation and curettage for the diagnosis of endometrial hyperplasia and cancer in perimenopausal women. Eur. J. Gynaecol. Oncol.28, 400–402 (2007).
   PubMed Web of Science ®Google Scholar
• Del Priore G, Grifo JA, Zhang JJ; NYU Cancer and Fertility group. Exploring a cancer patient’s reproductive options. Contemporary Ob/Gyn.53–66 (2002).
   Google Scholar
• Selvaggi, Cormio G, Ceci O, Loverro G, Cazzolla A, Bettocchi S. Hysteroscopy does not increase the risk of microscopic extrauterine spread in endometrial carcinoma. Int. J. Gynecol. Cancer13, 223–227 (2003).
   PubMedGoogle Scholar
• Solima E, Brusati V, Ditto A et al. hysteroscopy in endometrial cancer: new methods to evaluate transtubal leakage of saline distension medium. Am. J. Obstet. Gynecol.198, 214e1–214e4 (2008).
   Google Scholar
• Del Priore G, Zhang JJ, Grifo JA. Gamete cryopreservation and ovarian tissue transplantation. Contemporary Ob/Gyn.85–91 (2003).
   Google Scholar
• Meyerhoff AR, Noguchi-Minami A, Del Priore G. Comparison of endometrial aspiration biopsy techniques: specimen adequacy. Obstet. Gynecol.107(4 Suppl.), 55S–56S (2006).
   Google Scholar
• Silva-Filho AL, Carmo GAL, Athayde GRS et al. Safe fertility-preserving management in gynecological malignancies. Arch. Gynecol. Obstet.275, 321–330 (2007).
   PubMedGoogle Scholar
• Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil. Steril.88(3), 657–664 (2007).
   PubMed Web of Science ®Google Scholar
• Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet. Gynecol. Surv.62, 58–72 (2006).
   Google Scholar
• Kim YB, Holschneider CH, Gosh K et al. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer79, 320–327 (1997).
   PubMed Web of Science ®Google Scholar
• Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well differentiated carcinoma of the endometrium in women under age 40. Obstet. Gynecol.90, 434–440 (1997).
   PubMed Web of Science ®Google Scholar
• Ushijima K, Yahata H, Yoshikawa H et al. Multicenter Phase II study of fertility sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J. Clin. Onc.25, 2798–2803 (2007).
   PubMed Web of Science ®Google Scholar
• Hurst SA, Hartzfeld KM, Del Priore G. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer. Fertil. Steril.89(3), 724e1–7243e1 (2008).
   Google Scholar
• Montemarano N, Del Priore G, Gudipudi D, Nair A, Arslan A. Oral diindolyl methane (DIM): a non surgical treatment for cervical dysplasia. ASRM88, S16–S18 (2007) (abstract).
   Google Scholar
• Bell MC, Crowley-Nowick P, Bradlow HL et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol. Oncol.78, 123–129 (2000).
   PubMed Web of Science ®Google Scholar
• Restivo AM, Arslan AA, Goldberg GL, Del Priore G. Di-indolemethane a nonsurgical treatment of cervical intraepithelial neoplasia. Obstet. Gynecol.105; s45–s46 (2005).
   Google Scholar
• Einstein M, Kadish AS, Burk RD. Heat shock fusion protein- based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol. Oncol.106, 453–460 (2007).
   PubMed Web of Science ®Google Scholar
• Wallace WH, Thomson AB. Preservation of fertility in children treated for cancer. Arch. Dis. Child.88, 493–496 (2003).
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J. Natl Cancer Inst. Monogr.34, 64–68 (2005).
   Google Scholar
• Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal radiation. Int. J. Cancer43, 399–402 (1989).
   PubMed Web of Science ®Google Scholar
• Plante M, Roy M. Fertility-preserving options for cervical cancer. Oncology20(5), 479–488 (2006).
   PubMedGoogle Scholar
• Ungar L, Smith JR, Palfalvi L, Del Priore G. Abdominal radical trachelectomy during pregnancy to preserve pregnancy and fertility. Obstet. Gynecol.108, 811–814 (2006).
   PubMed Web of Science ®Google Scholar
• Ungar L, Palfalvi L, Boyle DCM, Del Priore G, Smith JR. Radical abdominal trachelectomy. In: An Atlas of Gynecologic Oncology, Investigation and Surgery. (Second Edition). Smith JR, Del Priore G, Curtin JP, Monaghan J (Eds). Martin Dunitz Publishing, London, UK, 12, 131–140 (2005).
   Google Scholar
• Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer88, 1877–1882 (2000).
   PubMedGoogle Scholar
• Sonoda Y, Abu-Rustum NR, Gemignani ML et al. A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible:? Gynecol. Oncol.95, 534–538 (2004).
   PubMed Web of Science ®Google Scholar
• Smith JR, Boyle DCM, Corless DJ et al. Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br. J. Obstet. Gynecol.104, 1196–1200 (1997).
   PubMedGoogle Scholar
• Plante M, Renaud MC, Harel F, Roy M. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol. Oncol.94, 614–623 (2004).
   PubMed Web of Science ®Google Scholar
• Plante M, Renaud MC, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of literature. Gynecol. Oncol.98, 3–10 (2005).
   PubMed Web of Science ®Google Scholar
• Schlearth JB, Spirtos NM, Schlearth AC. Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer. Am. J. Obstet. Gynecol.188, 29–34 (2003).
   PubMedGoogle Scholar
• Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by the recurrence and fertility rates. Br. J. Obstet. Gynaecol.108, 882–885 (2001).
   Google Scholar
• Burnett AF, Roman LD, O’Meara AT, Morrow CP. Radical vaginal trachelectomy, and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol. Oncol.88, 419–423 (2003).
   PubMedGoogle Scholar
• Shepherd JH, Spencer C, Herod J, Ind TEJ. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer – cumulative pregnancy rate in a series of 123 women. Br. J. Obstet. Gynecol.113, 719–724 (2006).
   Google Scholar
• Chalian R, Licciardi F, Rebarber A, Del Priore G. Successful infertility treatment in a cancer patient with a significant personal and family history of cancer. J. Women’s Health13, 235–237 (2004).
   PubMedGoogle Scholar
• Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J. Clin. Oncol.12, 701–706 (1994).
   PubMedGoogle Scholar
• Messing MJ, Gershenson DM, Morris M, Burke TW, Kavanagh JJ, Wharton JT. Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int. J. Gynecol. Cancer2, 295–300 (1992).
   PubMed Web of Science ®Google Scholar
• Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C. Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol. Oncol.55, S47–S51 (1994).
   PubMed Web of Science ®Google Scholar
• Colombo N, Parma G, Lapresa MT et al. Role of conservative surgery in ovarian cancer: the European experience. Int. J. Gynecol. Cancer15, 206–211 (2005).
   PubMedGoogle Scholar
• Schilder JM, Thompson AM, DePriest PD et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol. Oncol.87, 1–7 (2002).
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Avivi I, Eckman A, Epelbaum R, Rowe JM, Dann EJ. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin’s lymphoma. Fertil. Steril.89, 166–173 (2008).
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy. Minerva Endocrinol.32, 23–34 (2007).
   PubMedGoogle Scholar
• Blumenfeld Z. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist12, 1044–1054 (2007).
   PubMed Web of Science ®Google Scholar
• Paris F, Perez GI, Fuks Z et al. Sphingosine-1-phosphate preserves fertility in irradiated female mice without propagating genomic damage I offspring. Nat. Med.8, 901–902 (2002).
   PubMed Web of Science ®Google Scholar
• Spiegel S, Milstein S. Sphingosine-1-phosphte: an enigmatic signaling lipid. Nat. Rev. Mol. Cell. Biol.4, 397–407 (2003).
   PubMed Web of Science ®Google Scholar
• Recchia F, Saggio G, Amiconi G et al. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer106, 514–523 (2006).
   PubMed Web of Science ®Google Scholar
• Danforth DR, Arbogast LK, Friedman CI. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril.83, 1333–1338 (2005).
   PubMed Web of Science ®Google Scholar
• Meirow D, Assad G, Dor J, Rabinovici J. The GnRH antagonist cetorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum. Reprod.19, 1294–1299 (2004).
   PubMed Web of Science ®Google Scholar
• Gupta RK, Flaws JA. Gonadotropin releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles? Fertil Steril.83, 1339–1342 (2005).
   PubMedGoogle Scholar
• Morice P, Haie-Meder C, Pautier P et al. Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol. Oncol.83, 605–607 (2001).
   PubMedGoogle Scholar
• Toki N, Tsukamoto N, Kaku T et al. Microscopic ovarian metastasis of the uterine cervical cancer. Gynecol. Oncol.41, 46–51 (1991).
   PubMedGoogle Scholar
• Natsume N, Aoki Y, Kase H et al. Ovarian metastasis in stage IB and II cervical adenocarcinoma. Gynecol. Oncol.74, 255–258 (1999).
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. Fertility preservation in female patients. Hum. Reprod. Update10, 251–266 (2004).
   PubMed Web of Science ®Google Scholar
• Tilly JL, Johnson J. Recent arguments against germ cell renewal in the adult human ovary: is an absence of marker gene expression really acceptable evidence of an absence of oogenesis? Cell Cycle6, 879–883 (2007).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod.18, 90–95 (2003).
   PubMed Web of Science ®Google Scholar
• Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in-vitro fertilization. J. Clin. Endocrinol. Metab.92, 2197–2200 (2007).
   PubMed Web of Science ®Google Scholar
• Oktay K, Hourvitz A, Sahin G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J. Clin. Endocrinol. Metab.91, 3885–3890 (2006).
   PubMed Web of Science ®Google Scholar
• Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr. Relat. Cancer7, 227–242 (2000).
   PubMed Web of Science ®Google Scholar
• Fiorica JV, Brunetto VL, Hanjani P, Lentz SS, Mannel R, Anderson W. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol.92, 10–14 (2004).
   PubMed Web of Science ®Google Scholar
• Nair A, Zhang J, Silber S, Tran A, Wugmeister N, Chang L. Gentle ovarian stimulation in conjunction with elective vitrification of human embryos: a new approach for the practice of in-vitro fertilization. Fertil. Steril.88, S269–S269 (2007).
   Google Scholar
• Meirow D, Levron J, Eldar-Geva T et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Eng. J. Med.353(3), 318–321 (2005).
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet364, 1405–1410 (2004).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Veeck L et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet363, 837–840 (2004).
   PubMed Web of Science ®Google Scholar